Cinolazepam
From Wikipedia, the free encyclopedia
|
Cinolazepam
|
|
| Systematic (IUPAC) name | |
| 3-[9-chloro-6-(2-fluorophenyl)-4-hydroxy-3-oxo-2,5-diazabicyclo [5.4.0]undeca-5,8,10,12-tetraen-2-yl]propanenitrile |
|
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C18H13ClFN3O2 |
| Mol. mass | 357.8 |
| Pharmacokinetic data | |
| Bioavailability | 90-100% |
| Metabolism | Hepatic |
| Half life | 9 h[1] |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Unscheduled(US) |
| Routes | Oral |
Cinolazepam (Gerodorm[2]) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is used primarily as a hypnotic.
Cinolazepam is not approved for sale in the United States or Canada.
[edit] References
- ^ Saletu, B.; G. Kindshofer, P. Anderer, J. Grunberger (1987). "Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.". International Journal of Clinical Pharmacology Research 7 (5): 407–18. PMID 2889679.
- ^ Lannacher Romania (1999). Gerodorm (Romanian). Produse Gerot inregistrate in Romania. Retrieved on 17 August, 2006.
[edit] External links
|
|||||||||||||||||||||||||||||

